rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jane E. Kiernan

Director

Company insider

Files Form 4 as: Director, Treace Medical Concepts; Director, Axonics; Director, Endologix Inc /de/; Director, American Medical Systems Holdings.

In numbers

Trades disclosed
41
Buys
1
Sells
3
Bought
$100K
Sold
$742K
Companies
4
Companies where not an officer
4
First trade
27 Oct 2006
Last trade
19 May 2026
Last filed
19 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TMCI Treace Medical ConceptsDirector · Medical Devices · last 19 May 20261 buy · 0 sells
AxonicsDirector · last 15 Nov 20240 buys · 3 sells
Endologix Inc /de/Director · last 18 Mar 20200 buys · 0 sells
American Medical Systems HoldingsDirector · last 17 Jun 20110 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
19 May 2026filed 19 May 2026TMCI Treace Medical ConceptsMedical DevicesSEC FORM 4 Code A—30,000 at $0.00filing
19 May 2026filed 19 May 2026TMCI Treace Medical ConceptsMedical DevicesSEC FORM 4 Code A—30,000 at $0.00filing
20 May 2025filed 21 May 2025TMCI Treace Medical ConceptsMedical DevicesSEC FORM 4 Code A—23,917 at $0.00filing
15 Nov 2024filed 15 Nov 2024AxonicsSEC FORM 4 Code D$1.4M19,861 at $71.00filing
21 May 2024filed 22 May 2024TMCI Treace Medical Conceptsoption or derivative · Medical DevicesSEC FORM 4 Code A—33,260 at $0.00filing
21 May 2024filed 22 May 2024TMCI Treace Medical ConceptsMedical DevicesSEC FORM 4 Code A—15,091 at $0.00filing
14 May 2024filed 14 May 2024TMCI Treace Medical ConceptsMedical DevicesSEC FORM 4 Bought$100K19,356 at $5.17filing
26 Jun 2023filed 28 Jun 2023AxonicsSEC FORM 4 Code A—3,000 at $0.00filing
23 May 2023filed 25 May 2023TMCI Treace Medical Conceptsoption or derivative · Medical DevicesSEC FORM 4 Code A—6,305 at $0.00filing
23 May 2023filed 25 May 2023TMCI Treace Medical ConceptsMedical DevicesSEC FORM 4 Code A—2,753 at $0.00filing
1 Oct 2022filed 4 Oct 2022TMCI Treace Medical Conceptsoption or derivative · Medical DevicesSEC FORM 4 Code A—19,439 at $0.00filing
1 Oct 2022filed 4 Oct 2022TMCI Treace Medical ConceptsMedical DevicesSEC FORM 4 Code A—2,832 at $0.00filing
18 Aug 2022filed 22 Aug 2022AxonicsSEC FORM 4 Code A—2,100 at $0.00filing
5 Jul 2022filed 7 Jul 2022AxonicsSEC FORM 4 Sold$315K5,250 at $60.00filing
1 Apr 2022filed 7 Jul 2022AxonicsSEC FORM 4 Sold$110K1,750 at $62.71filing
29 Mar 2022filed 31 Mar 2022AxonicsSEC FORM 4 Sold$210K3,500 at $60.00filing
29 Mar 2022filed 31 Mar 2022AxonicsSEC FORM 4 Sold$108K1,750 at $61.49filing
22 Oct 2021filed 2 Nov 2021AxonicsSEC FORM 4 Code A—2,261 at $0.00filing
5 Aug 2021filed 7 Jul 2022Axonicsoption or derivativeSEC FORM 4 Code M—4,167 at $0.00filing
5 Aug 2021filed 7 Jul 2022Axonicsoption or derivativeSEC FORM 4 Code M—10,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Scot Michael ElderChief Legl & Comp Off, CorpSec · Chief Legl & Comp Off, CorpSec at Treace Medical Concepts, filing Form 4 there in the last year
John T. TreaceChief Executive Officer · Chief Executive Officer at Treace Medical Concepts, filing Form 4 there in the last year
Sean F. ScanlanChief Innovation Officer · Chief Innovation Officer at Treace Medical Concepts, filing Form 4 there in the last year
Mark HairChief Financial Officer · Chief Financial Officer at Treace Medical Concepts, filing Form 4 there in the last year
Betsy HannaDirector · Director at Treace Medical Concepts, filing Form 4 there in the last year